Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Biochim Biophys Acta Rev Cancer. 2022 Dec 16;1878(1):188851. doi: 10.1016/j.bbcan.2022.188851

Table 2 :

Various GEMMs used for IPMN Study

GEMM Phenotype Lesions/Tumor Time for Lesion Development IPMN Subtype Metastasis References
Ptf1a-Cre; LSL-KrasG12D; and Smad4f/f IPMN and PDAC 2–3 Months Gastric YES Bardeesy et al., 2006
P48-Cre; LSL-KrasG12D; and Ela-Tgfa IPMN, PanIN and PDAC 2–3 Months Pancreatobiliary YES Siveke et al., 2007
Pdx1-Cre; LSL-KrasG12D; and Tif1γf/f N/A 7 Weeks NA NA Vincent et al., 2009 Vincent et al., 2012
LSL-KrasG12D; Pdx1-Cre+/− and TP53INP−/− ADM, IPMN, PanIN 2 months NA NA Saati et. al., 2013
Ptf1a-Cre; LSL-KrasG12D; and Brg1f/f IPMN, PDAC 9 Weeks Pancreatobiliary NA Von Figura et al., 2014
Pdx1-Cre; LSL-KrasG12D; and Acvr1bf/f ADM, IPMN, PanIN, PDAC 3 Months NA YES Qiu et al., 2016
Pdx1-Cre; LSL-KrasG12D; and Tff2−/− IPMN, PDAC 6 Weeks Gastric YES Yamaguchi et al., 2016
Ptf1a-cre; LSL-KrasG12D; and CAG-LSL-GnasR201H; IPMN 5 Weeks Pancreatobiliary and Gastric N/A Taki et al., 2016
K5 COX-2. p48-Cre/KrasG12D IPMN, PanIN 1 Month Gastric NA Chiblak et all., 2016
P48-Cre;LSL-KrasG12D Rosa26R-LSL-rtTA-Tet-OGnasR201C IPMN (+Dox), PanIN (−Dox) 18 weeks Pancreatobiliary YES Ideno et al., 2018
Sox9-CreERT2; LSL-KrasG12D; and Ptenf/+ Sox9-CreER; LSL-KrasG12D; and Lkb1f/f IPMN 6–12 Months
4–8 months
Pancreatobiliary and Oncocytic

Pancreatobiliary
NA Kopp et al., 2018
Foxa3-Cre; HER2N IPMN, PanIN, 8 Weeks Pancreatobiliary and Oncocytic Shibata et al., 2018
Ptf1a-Cre; KrasG12D; and Arid1af/f IPMN, PDAC 2.3 Months Pancreatobiliary, Gastric and Oncocytic YES Wenjia Wang et al., 2019 Kimura et al., 2018
Sox9-CreER; LSL-KrasG12D; and Lkb1f/f IPMN, PanIN, 2 Months Gastric NA Collet et al.,2019
Ptf1aCre/+; Nr5a2lox/+; Kras(G12V)+/KI IPMN,, PanIN, PDAC 5 Months Pancreatobiliary NA Cobo et al., 2020
KrasLSL-G12D/+; Jag1flox/flox; Pdx1-Cre ADM, PanIN, SCN, IPMN 3 Weeks NA NA Chung et al., 2021